Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
Belantamab mafodotin is an important treatment option, but ocular toxicities remain a key challenge. This free webinar will bring together haematology, ophthalmology and nursing expertise to explore how these side effects can be recognised and managed effectively in practice. Expect practical, real-world insights and strategies you can use straight away.
Who should attend?
Any healthcare professional involved in the care of people with myeloma, or those with an interest in learning more about managing treatment-related side effects.
Chair and featured speakers:
Dr Jennifer Travers, Consultant Haematologist, Beatson West of Scotland Cancer Centre.
Dr Rakesh Popat, Consultant Haematologist, University College London Hospitals NHS Foundation Trust.
Prof Frank Larkin, Consultant Ophthalmic Surgeon, Moorfields Eye Hospital; Professor of Corneal Diseases (Hon.), University College London.
Christine Skeet, Haematology Clinical Nurse Specialist, Royal Derby Hospital.
–
